Moneycontrol PRO

Cipla: Targets for US complex generics on track

Cipla is looking at launching inhalation product Advair in the second half of FY23

May 12, 2022 / 11:49 AM IST
Cipla: Targets for US complex generics on track

PRO Only Highlights
Quarterly performance largely backed by improved realisations
Medium-term triggers China plus and protectionist measures for tyre industry
Valuations not inexpensive; but improved medium-term outlook

Cipla (CMP: Rs 938; Market Cap: Rs 75,639 crore) has posted a strong top-line growth, backed by both domestic and US businesses. Operational expenses, however, were higher -- partly due to the higher procurement cost and R&D expenses. While some of the cost headwinds in the post-COVID world would stay for a while, a healthy growth in the complex generics and consumer health segments for the company is noticeable. Q4FY22 financials (image) Source: Cipla The March quarter sales were up 14 percent year...

  • PRO Panorama

    Moneycontrol Pro​ Panorama | Auto wreck

    May 12, 2022 / 05:58 PM IST

    In today’s edition of Moneycontrol Pro​ Panorama: Bond yields flashing red, Sri Lankan crisis decoded, Jinping eyes third term, Start-Up Street and more

    Read Now
  • PRO Weekender

    Moneycontrol Pro Weekender | Losing faith

    May 7, 2022 / 10:05 AM IST

    Central banks have a trust problem with financial markets over their ability to steer economies towards a soft landing

    Read Now

To read the full story, Subscribe to Moneycontrol PRO

Access the exclusive stories, weekly investment ideas and daily technical calls in an Ad free experience

Already a member? Sign in

Limited Period offer on Moneycontrol PRO. Subscribe to PRO and get up to

50% OFF

What Do You Get

  • Ad free experience

    Experience a non-intrusive navigation and faster response in the ad free mode

  • Sharpest Opinions

    Access to 230+ exclusive stories per month from our editorial and Experts

  • +

    Have a Global edge with access to content from world renowned experts and journalist

  • Actionable Insights

    Access to 40+ weekly investment ideas including 4 daily technical calls

  • Virtual Events

    Exclusive access to live webinars from market experts on trading and investment strategies

  • Newsletters

    Daily and weekly insights bundled and sent to your inbox to keep you ahead in the race.

Get upto 50% discount on limited period offers